Literature DB >> 10375176

Studies on interactions between traditional herbal and Western medicines. I. Effects of Sho-seiryu-to on the pharmacokinetics of carbamazepine in rats.

N Ohnishi1, Y Yonekawa, S Nakasako, K Nagasawa, T Yokoyama, M Yoshioka, K Kuroda.   

Abstract

The effects of oral co- and pre-administration of Sho-seiryu-to extract powder (TJ-19, 1 g/kg), a widely used Kampo (traditional Chinese herbal) medicine, on the pharmacokinetics of an anti-epileptic drug, carbamazepine (CBZ), and its active metabolite (carbamazepine-10,11-epoxide, CBZ-E) after oral administration of CBZ (50 mg/kg) were examined in male rats. The simultaneous administration of TJ-19 significantly lengthened the time to reach the peak plasma concentration (Tmax), but did not influence the peak plasma concentration, area under the plasma concentration-time curve or terminal elimination half-life (t1/2). Each parameter for CBZ or CBZ-E with a single pretreatment with TJ-19 was not significantly different from that with the vehicle. Tmax and the elimination rate constant for CBZ were significantly increased by 1-week repeated pretreatment with TJ-19, by 83% (p<0.01) and 88% (p<0.001), respectively. t1/2 and the mean residence time from zero to infinity (MRT0-infinity) in the TJ-19 pretreatment group were significantly shortened, by 52 and 34% (p<0.005), respectively. No significant difference in the bound fraction of each drug at two concentrations (1 and 10 microg/ml) was observed between the control and TJ-19 pretreatment groups. These results indicate that simultaneous oral administration of TJ-19 delays the oral absorption of CBZ, while 1-week repeated pretreatment with TJ-19 accelerates the metabolism of CBZ in rats, without affecting the protein binding of CBZ.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10375176     DOI: 10.1248/bpb.22.527

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  6 in total

1.  Pharmacokinetic interaction studies of fenugreek with CYP3A substrates cyclosporine and carbamazepine.

Authors:  Fahad I Al-Jenoobi; Mohd Aftab Alam; Khalid M Alkharfy; Saleh A Al-Suwayeh; Hesham M Korashy; Abdullah M Al-Mohizea; Muzaffar Iqbal; Abdul Ahad; Mohammad Raish
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-06       Impact factor: 2.441

2.  Studies on interactions between traditional herbal and Western medicines. IV: lack of pharmacokinetic interactions between Saiko-ka-ryukotsu-borei-to and carbamazepine in rats.

Authors:  N Ohnishi; S Nakasako; K Okada; S Umehara; K Takara; K Nagasawa; M Yoshioka; K Kuroda; T Yokoyama
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jan-Jun       Impact factor: 2.441

3.  Effect of Curcuma longa on CYP2D6- and CYP3A4-mediated metabolism of dextromethorphan in human liver microsomes and healthy human subjects.

Authors:  Fahad Ibrahim Al-Jenoobi; Areej A Al-Thukair; Mohd Aftab Alam; Fawkeya A Abbas; Abdullah M Al-Mohizea; Khalid M Alkharfy; Saleh A Al-Suwayeh
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-02-09       Impact factor: 2.441

Review 4.  Interaction of carbamazepine with herbs, dietary supplements, and food: a systematic review.

Authors:  Sophia Yui Kau Fong; Qiong Gao; Zhong Zuo
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-19       Impact factor: 2.629

5.  Modulation of CYP2D6 and CYP3A4 metabolic activities by Ferula asafetida resin.

Authors:  Fahad I Al-Jenoobi; Areej A Al-Thukair; Mohd Aftab Alam; Fawkeya A Abbas; Abdullah M Al-Mohizea; Khalid M Alkharfy; Saleh A Al-Suwayeh
Journal:  Saudi Pharm J       Date:  2014-04-03       Impact factor: 4.330

6.  Effects of concurrent and staggered dosing of semi-solid enteral nutrients on pharmacokinetic behavior of antiepileptic drugs after oral administration in rats.

Authors:  Katsuhito Nagai; Yoshikazu Ryuno; Yoshihito Iwanami; Sachiko Omotani; Shuhei Fukuno; Yasutoshi Hatsuda; Hiroki Konishi; Michiaki Myotoku
Journal:  PLoS One       Date:  2021-11-09       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.